# EnVVeno Medical Corporation (NVNO)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Market cap:** $7M  
**Price:** $10.27 (+2.70%)

> EnVVeno Medical Corporation is a biomedical company focused on the development and commercialization of innovative medical treatments. Primarily, the corporation is dedicated to addressing unmet medical needs pertaining to vascular diseases, with a notable emphasis on venous conditions. The company's flagship product centers around a specialized prosthetic device aimed at treating chronic venous insufficiency (CVI), a condition prevalent due to valve failure in veins, leading to poor circulation and various complications. EnVVeno Medical's research and development efforts are channeled towards creating effective solutions that improve patient outcomes and enhance quality of life for individuals affected by these vascular issues. Operating within the healthcare and biotechnology sector, EnVVeno Medical is a key contributor to advancements in medical technology, with its innovative approach underscoring its importance in the medical devices market. By prioritizing cardiovascular health, the corporation plays a critical role in the healthcare industry, supporting the broader objective of developing cutting-edge treatments and addressing critical health challenges.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2019 | $31,243 | — | -$8M | -$8M | — |
| 2018 | $186,552 | $186,552 | -$8M | -$13M | — |
| 2017 | $422,111 | $2,452 | -$6M | -$8M | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2019 | $3M | $2M | $989,940 | $1M | — |
| 2018 | $4M | $2M | $2M | $3M | — |
| 2017 | $2M | $8M | -$11M | $77,688 | — |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | -$16M | $5,000 | -$16M |
| 2024 | -$17M | $37,000 | -$17M |
| 2023 | -$19M | $33,000 | -$19M |
| 2022 | -$16M | $115,000 | -$16M |
| 2021 | -$12M | $368,000 | -$12M |
| 2020 | -$8M | $180,291 | -$8M |
| 2019 | -$6M | $363,891 | -$6M |
| 2018 | -$6M | $12,422 | -$6M |
| 2017 | -$4M | $10,938 | -$4M |

Source: [CompaniesByCap](https://companiesbycap.com/company/NVNO)